Lista de obras -

A human anti-neuronal autoantibody against GABA B receptor induces experimental autoimmune agrypnia

artículo científico publicado en 2007

Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures

artículo científico publicado en 2016

Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis

artículo científico publicado en 2005

Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients

scientific article published on 12 July 2007

IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis

artículo científico publicado en 2008

In vivo effects of mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients.

artículo científico publicado en 2006

Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta

scientific article published on 01 June 2003

Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients.

artículo científico publicado en 2004

MRI versus CT in acute stroke.

artículo científico publicado en 2007

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

artículo científico publicado en 2005

Potential Role of OERP as Early Marker of Mild Cognitive Impairment

Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients

artículo científico publicado en 2008

Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.

scientific article published on January 2005

Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion.

artículo científico publicado en 2013

Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis.

artículo científico publicado en 2008

The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis

artículo científico publicado en 2007

[A case of Anderson-Fabry disease: a multidisciplinary approach for diagnosis and follow up]

scientific article published on 01 September 2018

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity

artículo científico publicado en 2006

Lista de obras de

A human anti-neuronal autoantibody against GABA B receptor induces experimental autoimmune agrypnia

Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures

Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis

Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients

IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis

In vivo effects of mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients.

Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta

Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients.

MRI versus CT in acute stroke.

Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy

Potential Role of OERP as Early Marker of Mild Cognitive Impairment

Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients

Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.

Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion.

Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis.

The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis

[A case of Anderson-Fabry disease: a multidisciplinary approach for diagnosis and follow up]

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity